About CELLINK
CELLINK is a publicly listed company based in Boston (United States) founded in 2016. 3D bioprinters and bioinks are developed for research applications. It operates in the Healthcare and Technology sectors. CELLINK has completed 8 acquisitions, including Cytena, Dispendix and Echo Laboratories. Its website cellink.com draws about 56 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and 3D Bioprinting. Its competitors include Precise Bio and Allevi; 2 of its 2 listed competitors have raised funding.
Company details
CELLINK was founded in 2016 in Boston, United States, within the biotechnology sector. 3D bioprinters are designed and developed for applications in cell culture, tissue engineering, and drug development. Bioinks, single-cell dispensers, liquid handlers, bioreactors, live-cell analyzers, omics tools, NGS reagents, biomaterials, and various consumables are also provided to support research operations.
- Latest Funding Round$323.15M (USD), Post-IPO
Mar 2021
- Investors
- Investments & AcquisitionsCytena
& 7 more
Apps and channels of CELLINK
its YouTube channel CELLINK has 625 subscribers and 27 videos.
Videos from CELLINK
The most watched videos on CELLINK's YouTube channel, CELLINK (625 subscribers). Click a video to play it here.
More on CELLINK.
Funding Insights of CELLINK
- Total Rounds 12
- Last Round Post-IPO — $323.15M
- First Round $543,341
(Oct 2016)
- Investors Count 1
Latest 10 of 12 funding rounds of CELLINK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $323.15M | Post-IPO | – | – | – |
| Jan 2021 | $762,646 | Grant | – | – | |
| Sep 2020 | $321,917 | Grant | – | – | |
| Jun 2019 | $15.98M | Post-IPO | – | – | – |
| Jan 2019 | $1M | Grant | – | – | |
| Jan 2019 | $343,826 | Grant | – | – | |
| Sep 2018 | $2.85M | Grant | – | – | |
| Jul 2018 | $29.21M | Grant | – | – | |
| Jun 2018 | $11.31M | Post-IPO | – | – | – |
| Jan 2018 | $2.92M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in CELLINK
CELLINK has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for CELLINK
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CELLINK
36 people are tracked at CELLINK (8 in leadership, 28 in team).
| Name | Role | Group |
|---|---|---|
Oscar Gedda | Head Of Finance | Leadership |
Karin Danielsson | Global HR Director | Leadership |
Andrew Ridley | Head of Sales (Europe) | Leadership |
Stefan Blomsterberg | CEO | Leadership |
Tomoko Bylund | Head Of Sales, APAC | Leadership |
Avijit Minocha | Chief Commercial Officer (cco) | Leadership |
Wei Zhu | CTO | Leadership |
Rahul Roy | Director of Product Development | Leadership |
Nadia Peerboom | Technical Project Manager | Team |
Josefin Svensson | Global Payroll & Policy | Team |
Brandy Hopkins | US HR Manager | Team |
Pauline Ojala | Marketing Associate - Europe | Team |
Christian Silva | Field Application Specialist | Team |
Amir Khairalla | Inside Sales Representative - Bioprinting | Team |
Anna Strokovsky | Global Payroll & HR Admin | Team |
Paulo Godoy, PhD | Senior Scientist Biodispensing R&d Lead | Team |
anglina cassie | Financial Accountant | Team |
Desislava Chukarska | Marketing Manager EU | Team |
Jean-Gabriel Pannolié | Inside Sales Representative | Team |
Daniel Ong | Senior Sales Executive | Team |
16 more people are available in the full profile.
Complete people profiles for CELLINK
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CELLINK
CELLINK has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Cytena, Dispendix and Echo Laboratories.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Hybrid optical microscope | discover-echo.com | San Diego, United States | 2013 | Jun 2021 | $110M | |
Optical clearing agents for tissue transparency are developed by Visikol. | visikol.com | New Brunswick, United States | 2012 | May 2021 | •••• | |
3D printing services are provided by Nanoscribe in Germany. | nanoscribe.com | Eggenstein Leopoldshafen, Germany | 2007 | May 2021 | $61.01M | |
Focused on development, optimization, and commercialization of in vitro models and methods. | mattek.com | Ashland, United States | 1985 | Mar 2021 | $68M | |
Liquid handling and lab automation robots | ginolis.com | Oulunsalo, Finland | 2010 | Feb 2021 | $84.83M | |
Non-contact dispensing solutions for genomics and proteomics are provided. | scienion.com | Berlin, Germany | 2000 | Aug 2020 | $95.31M | |
Single cells are isolated using the cy-Clone device technology. | cytena.com | 2014 | Aug 2019 | $33.59M | ||
Non-contact nanoliter dispensing technology is developed and offered. | dispendix.com | Stuttgart, Germany | 2015 | Nov 2018 | $5.69M |
Complete acquisition details for CELLINK
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CELLINK
12 dated milestones of CELLINK across 5 years, from founding to its latest funding, stage changes and deals.
- Founded CELLINK is founded.
- Funding First funding round of $543K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Dispendix.
- Acquisition Acquires Cytena.
- Acquisition Acquires Scienion.
- Acquisition Acquires Ginolis.
- Funding Latest funding round, Post-IPO, of $323.1M.
- Acquisition Acquires MatTek.
- Acquisition Acquires Visikol®.
- Acquisition Acquires Nanoscribe.
- Acquisition Acquires Echo Laboratories.
Competitors of CELLINK
CELLINK has 2 listed competitors in our database, 2 of them funded. They include Precise Bio and Allevi.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| precise-bio.com | 2015 | Winston-salem, United States | $12M | 6 | Developer of integrated 3D printing and tissue-engineering platform | |
| allevi3d.com | 2014 | Philadelphia, United States | $3.58M | Industrial-grade 3D bioprinters and bioprinting materials are manufactured. |
Detailed competitors of CELLINK
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CELLINK
The website of CELLINK (cellink.com) receives about 56.1K visits a month.
- Monthly visits56.1K
▼ 21.6% vs previous month
Websites whose visitors overlap most with CELLINK. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| upmbiomedicals.com | 100% | View details | |||
| stellarscientific.com | 92% | #769,148 | View details | ||
fishersci.no | fishersci.no | 92% | #1,225,949 | – | |
| nippongenetics.eu | 81% | #997,372 | View details | ||
| facellitate.com | 75% | 32K | #997,034 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for CELLINK
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as CELLINK (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellink
Complete news archive for CELLINK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CELLINK
CELLINK was founded in 2016.
CELLINK is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
CELLINK was founded in 2016 in Boston, United States, within the biotechnology sector. 3D bioprinters are designed and developed for applications in cell culture, tissue engineering, and drug development. Bioinks, single-cell dispensers, liquid handlers, bioreactors, live-cell analyzers, omics tools, NGS reagents, biomaterials, and various consumables are also provided to support research operations.
CELLINK's top competitors include Allevi and Precise Bio.
CELLINK has made 8 acquisitions, including Cytena, Dispendix, and Echo Laboratories.
CELLINK has 1 investor. Key investors include European Union.